• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

正电子发射断层成像术的代谢、灌注和缺氧显像:FDG 及其他

PET Imaging of Metabolism, Perfusion, and Hypoxia: FDG and Beyond.

机构信息

From the Department of Radiology, University of Pennsylvania, Philadelphia, PA.

Department of Cancer Systems Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX.

出版信息

Cancer J. 2024;30(3):159-169. doi: 10.1097/PPO.0000000000000716.

DOI:10.1097/PPO.0000000000000716
PMID:38753750
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11101148/
Abstract

Imaging glucose metabolism with [18F]fluorodeoxyglucose positron emission tomography has transformed the diagnostic and treatment algorithms of numerous malignancies in clinical practice. The cancer phenotype, though, extends beyond dysregulation of this single pathway. Reprogramming of other pathways of metabolism, as well as altered perfusion and hypoxia, also typifies malignancy. These features provide other opportunities for imaging that have been developed and advanced into humans. In this review, we discuss imaging metabolism, perfusion, and hypoxia in cancer, focusing on the underlying biology to provide context. We conclude by highlighting the ability to image multiple facets of biology to better characterize cancer and guide targeted treatment.

摘要

使用 [18F]氟代脱氧葡萄糖正电子发射断层扫描成像来检测葡萄糖代谢已经改变了临床实践中许多恶性肿瘤的诊断和治疗策略。然而,肿瘤表型并不仅限于该单一途径的失调。其他代谢途径的重编程以及血流灌注和缺氧的改变也是恶性肿瘤的典型特征。这些特征为已经在人体中开发和推进的其他成像机会提供了可能。在这篇综述中,我们讨论了癌症中的代谢、灌注和缺氧成像,重点介绍了潜在的生物学知识以提供背景信息。最后,我们强调了能够对多个生物学方面进行成像以更好地对肿瘤进行特征描述和指导靶向治疗的能力。

相似文献

1
PET Imaging of Metabolism, Perfusion, and Hypoxia: FDG and Beyond.正电子发射断层成像术的代谢、灌注和缺氧显像:FDG 及其他
Cancer J. 2024;30(3):159-169. doi: 10.1097/PPO.0000000000000716.
2
Imaging of Tumor Metabolism Using Positron Emission Tomography (PET).使用正电子发射断层扫描(PET)对肿瘤代谢进行成像
Recent Results Cancer Res. 2016;207:177-205. doi: 10.1007/978-3-319-42118-6_8.
3
Revisit 18F-fluorodeoxyglucose oncology positron emission tomography: "systems molecular imaging" of glucose metabolism.重新审视18F-氟脱氧葡萄糖肿瘤正电子发射断层扫描:葡萄糖代谢的“系统分子成像”
Oncotarget. 2017 Jun 27;8(26):43536-43542. doi: 10.18632/oncotarget.16647.
4
Hypoxia and glucose metabolism in malignant tumors: evaluation by [18F]fluoromisonidazole and [18F]fluorodeoxyglucose positron emission tomography imaging.恶性肿瘤中的缺氧与葡萄糖代谢:通过[18F]氟米索硝唑和[18F]氟脱氧葡萄糖正电子发射断层显像进行评估
Clin Cancer Res. 2004 Apr 1;10(7):2245-52. doi: 10.1158/1078-0432.ccr-0688-3.
5
Imaging Cancer Metabolism: Underlying Biology and Emerging Strategies.影像学在癌症代谢研究中的应用:基础生物学与新兴策略。
J Nucl Med. 2018 Sep;59(9):1340-1349. doi: 10.2967/jnumed.117.199869. Epub 2018 Jul 24.
6
FDG and Beyond.氟代脱氧葡萄糖及其他
Recent Results Cancer Res. 2016;198:163-73. doi: 10.1007/978-3-662-49651-0_8.
7
Measuring response with FDG-PET: methodological aspects.使用氟代脱氧葡萄糖正电子发射断层扫描(FDG-PET)测量反应:方法学方面。
Oncologist. 2009 Apr;14(4):369-77. doi: 10.1634/theoncologist.2008-0119. Epub 2009 Apr 8.
8
Likely Common Role of Hypoxia in Driving F-FDG Uptake in Cancer, Myocardial Ischemia, Inflammation and Infection.缺氧可能在促进癌症、心肌缺血、炎症和感染中摄取 F-FDG 中发挥共同作用。
Cancer Biother Radiopharm. 2021 Oct;36(8):624-631. doi: 10.1089/cbr.2020.4716. Epub 2021 Aug 10.
9
Focal fluorine-18 fluorodeoxyglucose-avid lesions without computed tomography correlate at whole-body positron emission tomography-computed tomography in oncology patients: how often are they malignant?在肿瘤患者的全身正电子发射断层扫描-计算机断层扫描中,氟-18氟脱氧葡萄糖摄取灶在计算机断层扫描上无对应表现:这些病灶为恶性的频率有多高?
Nucl Med Commun. 2011 Sep;32(9):802-7. doi: 10.1097/MNM.0b013e3283483e04.
10
[Understanding positon emission tomography (PET) with [18F]-FDG in clinical oncology. Informations dedicated to patients and relatives].[了解[18F]-FDG正电子发射断层扫描(PET)在临床肿瘤学中的应用。面向患者及家属的信息]
Bull Cancer. 2005 Jul;92(7):723-32.

本文引用的文献

1
F-Labeled Fluoroestradiol PET/CT: Current Status, Gaps in Knowledge, and Controversies- Expert Panel Narrative Review.F-标记氟雌二醇 PET/CT:现状、知识空白和争议——专家小组叙事性综述。
AJR Am J Roentgenol. 2024 Oct;223(4):e2330330. doi: 10.2214/AJR.23.30330. Epub 2023 Dec 20.
2
Is System x a Suitable Target for Tumour Detection and Response Assessment with Imaging?系统x是否适合作为肿瘤检测和成像反应评估的靶点?
Cancers (Basel). 2023 Nov 24;15(23):5573. doi: 10.3390/cancers15235573.
3
[O]HO PET: Potential or Essential for Molecular Imaging?
[O]HO PET:分子成像的潜在还是必需标志物?
Semin Nucl Med. 2024 Sep;54(5):761-773. doi: 10.1053/j.semnuclmed.2023.08.002. Epub 2023 Aug 26.
4
Targeting mitochondrial oxidative phosphorylation: lessons, advantages, and opportunities.靶向线粒体氧化磷酸化:教训、优势和机遇。
Br J Cancer. 2023 Oct;129(6):897-899. doi: 10.1038/s41416-023-02394-9. Epub 2023 Aug 10.
5
Oxidative phosphorylation is a metabolic vulnerability of endocrine therapy and palbociclib resistant metastatic breast cancers.氧化磷酸化是内分泌治疗和帕博西尼耐药转移性乳腺癌的代谢脆弱性。
Nat Commun. 2023 Jul 14;14(1):4221. doi: 10.1038/s41467-023-40022-5.
6
Role of FDG PET/CT in Management of Patients with Prostate Cancer.氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描(FDG PET/CT)在前列腺癌患者管理中的作用
Semin Nucl Med. 2024 Jan;54(1):4-13. doi: 10.1053/j.semnuclmed.2023.06.005. Epub 2023 Jul 1.
7
Hybrid F-FET PET and Perfusion MRI to Differentiate Disease Progression from Treatment-Related Changes in Malignant Brain Tumors.混合F-FET正电子发射断层扫描与灌注磁共振成像鉴别恶性脑肿瘤疾病进展与治疗相关变化
J Nucl Med. 2023 Jul;64(7):1093-1094. doi: 10.2967/jnumed.123.265647. Epub 2023 May 18.
8
Hybrid F-Fluoroethyltyrosine PET and MRI with Perfusion to Distinguish Disease Progression from Treatment-Related Change in Malignant Brain Tumors: The Quest to Beat the Toughest Cases.氟代乙基酪氨酸 PET 和灌注 MRI 融合成像鉴别脑恶性肿瘤的疾病进展与治疗相关性改变:攻克最棘手病例的探索。
J Nucl Med. 2023 Jul;64(7):1087-1092. doi: 10.2967/jnumed.122.265149. Epub 2023 Apr 28.
9
Advances in PET Diagnostics for Guiding Targeted Cancer Therapy and Studying In Vivo Cancer Biology.用于指导癌症靶向治疗和研究体内癌症生物学的PET诊断进展。
Curr Pathobiol Rep. 2019 Sep;7(3):97-108. doi: 10.1007/s40139-019-00202-9. Epub 2019 Jul 25.
10
FDG PET/CT-based Response Assessment in Malignancies.基于 FDG PET/CT 的恶性肿瘤反应评估。
Radiographics. 2023 Apr;43(4):e220122. doi: 10.1148/rg.220122.